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Abstract
Background: Variations in cardiovascular disease risk (CVD) are suggested to be partly influenced by factors that
affect prenatal growth patterns and outcomes, namely degree of maternal investment (proxied by birth weight and
gestational age). Using the life history trajectory model, this study investigates whether maternal investment in early
prenatal life associates with menarcheal age and whether maternal investment affects CVD risk in adulthood and
predicts adult size and adiposity levels.
Methods: A cross-sectional study was conducted among 94 healthy Emirati females. Birth weight, gestational age
and menarcheal age were obtained. Anthropometrical measurements, body composition analysis, and blood
pressure values were collected. Regression analyses were conducted to establish associations.
Results: There was no association between birth weight standard deviation score (SDS) and age at menarche.
When investigating the associations of birth weight SDS and age at menarche with growth indices, it was found
that only birth weight was positively and significantly associated with both height (β = 1.342 cm, 95% CI (0.12, 2.57),
p = 0.032) and leg length (β = 0.968 cm, 95% CI (0.08, 1.86), p = 0.034). Menarcheal age was significantly and
inversely associated with fat mass index (FMI) (β = − 0.080 cm, 95% CI (− 0.13, − 0.03), p = 0.002), but not with waist
circumference and fat free mass index (FFMI) (p > 0.05). Birth weight SDS was positively and significantly associated
with waist circumference (β = 0.035 cm, 95% CI (0.01, 0.06), p = 0.009), FMI (β = 0.087 cm, 95% CI (0.01, 0.16), p =
0.027), and FFMI (β = 0.485 cm, 95% CI (0.17, 0.80), p = 0.003). Birth weight SDS was not significantly associated with
either systolic blood pressure (SBP) or diastolic blood pressure (DBP) (p > 0.05). However, FMI, waist circumference,
and FFMI were positively and significantly associated with SBP. Regarding DBP, the relationship was negatively and
significantly associated with only FFMI (β = − 1.6111 kg/m2, 95% CI (− 2.63, − 0.60), p = 0.002).
Conclusion: Although the results do not fully support that Emirati females fast-life history is associated with
increased chronic disease risk, the data does suggest a link between restricted fetal growth in response to low
maternal investment and metabolic and reproductive health.
Keywords: Adiposity, low birth weight, Maternal investment, Life-history trajectory, Cardiovascular disease
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Background
Current World Health organization (WHO) statistics
have reported Cardiovascular Disease (CVD) to be the
leading cause of mortality worldwide with an estimation
of 17.9 million deaths each year [1]. In the United Arab
Emirates (UAE), the burden of CVD is no different,
where a recent report estimates that 40% of total deaths
are linked to CVD [2]. The aetiology of heart disease is
complex and multifactorial [3], however there are various factors that have been implicated in increasing disease risk. Lifestyle risk factors include smoking, physical
inactivity, obesity (with strong emphasis on central/visceral adiposity) and alcohol intake [4]. These behavioral
risk factors are often manifested into one or more of the
following: high blood pressure (BP), insulin resistance,
diabetes, increased blood lipids, and even kidney dysfunction [5, 6].
Hypertension is a highly prevalent condition that affects up to 1.13 billion adults all over the world and is
highly incriminated in increased risk of CVD amongst
other chronic conditions [7]. Normal readings of both
systolic blood pressure (SBP) and diastolic blood pressure (DBP) are essential to optimal functioning of all
vital organs. However, studies have demonstrated that
SBP is possibly more significant as an independent predictor of risk for stroke, heart failure and other coronary
events [8]. Numerous factors contribute to the development of hypertension, including intrauterine growth restriction (IUGR), which has been linked to high BP in
adulthood. This could be attributed to the effect that restricted growth has on the number of nephrons an individual develops, a number that is set at birth [5, 9].
Mounting evidence has found that retarded growth in
utero is significantly associated with a reduction in
nephron number, which in turn is a risk factor for the
development of hypertension. Animal studies have
shown that rats subjected to growth retardation by
restricting maternal protein intake presented with a
nephron deficit in comparison to the control group [10].
Therefore, low birth weight for gestational age can be
used as a marker to link intrauterine growth and the effect maternal investment potentially had on the offspring’s capacity for maintaining metabolic homeostasis
[5]. A multitude of studies have demonstrated the significant links between low birth weight and elevated BP
in adults [5, 11, 12]. In 2020, Aye et al. [13], reported
that maternal hypertension was associated with ‘both
prenatal and postnatal differences in cardiac development, with right ventricular changes proportional to the
severity of the pregnancy disorder’. Yet, long term effect
and relationship to CVD is still not fully explored as
more work is needed to determine if these changes persist into adulthood and whether they impact the physical, respiratory, and cardiac functions [13].
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Adiposity-related health consequences are well known
and documented, and high adiposity levels have been
linked to numerous chronic diseases including CVD
[14]. Body Mass Index (BMI) continues to be used as a
marker for obesity levels and disease risk, however it is
just as important to take into account body fat distribution due to the fact that excess central adiposity is detrimental to health and is highly correlated with a host of
metabolic diseases including increased CVD risk [14].
Because precise measurement of central fat is expensive
and requires radiological imaging, waist circumference is
accepted and often used as a surrogate marker instead
[15]. Evidence suggests that the intrauterine environment as well as the early infancy period could be responsible for shaping body composition in later life, where
several studies have found an inverse association between birth weight and greater BMI as well as higher abdominal obesity levels (larger waist circumference) [16–
18]. A cohort study of indigenous Australians found that
those with the highest CVD risk were both in the highest waist circumference quartile group and of low birth
weight [19]. Boscaini & Pellanda [20] revealed that high
birth weight individuals had higher BMI and waist circumference. This implies that the relationship is much
more complex and our understanding of it needs further
exploration [21]. Sex is another factor added to the birth
weight and adiposity association. Rockenbach et al. [22]
examined sex-specific relationship of birth weight with
measures of adiposity. Results in men showed that low
birth weight was linked with lower adiposity while low
birth weight in females showed greater adiposity [22].
The risk factors explored above are only able to predict disease risk up to a limited point. So far, the lifestyle
model has only been successful in partly explaining
CVD risk by exploring lifestyle interactions with underlying genetic influences [23]. Other theories were developed in an attempt to explain the complex nature of
heart disease aetiology to help understand how prenatal
period influences can bridge the gap in our understanding of both CVD aetiology [24] and prenatal associations
with chronic disease susceptibility [25].
Hales and Barker [26], in accordance with earlier observations by Forsdahl [27], proposed one of the earliest
models explaining this link. They found that CVD mortality rates were recorded to be highest in areas of poverty that were exposed to later prosperity. If later
affluence and nutritional overabundance in childhood
and adulthood was not experienced, the risk did not appear to be increased [27]. This implied that energy insufficiency in-utero could affect the ability to manage
nutritional affluence (excessive intake of energy) later on
in life [5]. They suggested that CVD and other chronic
diseases are ‘programmed’ during critical windows in
fetal life and even into early infancy. This hypothesis was
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termed ‘fetal origins of adult disease’ [28]. Research has
found that suboptimal nutrition in-utero, particularly
halfway through the gestational period, increases CVD
risk in adulthood by “the programming of blood pressure, cholesterol metabolism, blood coagulation, and
hormonal settings” [24]. Specifically, arteriosclerotic
heart disease was linked to an increase in serum cholesterol levels in those who grew up in least affluent households and were exposed to a high fat diet [27].
Although past studies have shown that biological programming in prenatal life as a response to nutritional affluence or lack of is an important factor to consider, it is
important to also take into account how lifestyle measures later on in life affect the degree of disease manifestation. To address this issue, Wells et al. [5] went on
to propose a ‘capacity-load’ model for risk of disease.
This builds on the original ‘thrifty phenotype’ hypothesis
by Hales and Barker [26] and incorporates two different
variables: metabolic capacity and metabolic load. The
former refers to the ability to maintain homeostasis
throughout adulthood and stems from prenatal growth
(birth weight and gestational age). The latter is defined
as various stresses that strain cardio-metabolic function,
such as obesity, smoking, sedentary lifestyle and
inflammation.
During critical windows in gestation, “epigenetic processes are thought to alter gene expression in the fetus
based on maternal environmental cues” [29] in order to
best prepare the fetus for the extra uterine environment.
A ‘mismatch’ in the predicted environment due to exposure to nutritional affluence post birth is proposed to
increase disease risk. Therefore, the phenotype developed during those windows of under nutrition in order
to aid in survival, results in lower ability to tolerate
metabolic load later on in life [30]. In this context, diminished metabolic capacity becomes an issue only
when metabolic load is intensified [30]. This explains
why individuals who are not exposed to nutritional affluence after birth do not appear to have heightened metabolic risk even if exposed to malnutrition in the uterine
environment [5]. It also explains why those born with a
lower birth weight (lower metabolic capacity) and become large (high metabolic load) exhibit higher risk of
CVD [5, 31, 32]. Wells et al. [5] also suggested that lifehistory theory could explain why individuals have varying ranges of load and capacity. This theory proposes
that individuals must allocate their energy resources in a
way that maximizes fitness. They can either invest in
characteristics that “affect the age-schedule of mortality;
or in traits that affect the age-schedule of fertility” [33].
For example, investing in reproductive fitness (higher
adiposity stores) could reduce investment in growth.
This theory could be used to justify why energy allocation during periods of nutritional insufficiency during
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the life course is directed towards reproductive functions
instead of maintenance ones [34]. According to this evolutionary theory, individuals who were recipients of diminished maternal investment (restricted nutritional
environment in utero proxied by lower birth weight and
shorter gestational period) can be said to have a fastpaced life-history strategy [5]. This translates to earlier
maturation in the form of earlier menarche as well as a
shorter stature. This is suggested to lead to a reduced
metabolic capacity, and a high metabolic load that increases CVD risk. So, lower maternal investment
faster pace of life history
lower adult height,
higher energy stores for reproduction and lower metabolic health. In other words, low birth
weight
earlier maturation + shorter height
later increased
adiposity. The opposite holds true for those receiving
high maternal investment and optimal nutrition in fetal
life [5]. In 2018, Wells proposed the relative partitioning
concept of maternal investment between fetal life and
infancy. This analytical framework suggests that low fetal
weight gain diminishes the energy needed for growth
and maintenance, and if continued, growth postnatally
will continue to be constrained. This leads to earlier menarche and reproductive maturation, small adult size, elevated fat stores. ‘Through the partitioning described
above, the combination of short adult stature and high
fatness favour the same trade-offs emerging in the next
generation’ [35]. Bleil et al. [36] reported that younger
menarcheal age was related to greater CVD risk. A study
conducted in the UK found that less than optimal maternal investment led to faster life histories which were
marked by earlier menarcheal age, shorter stature and
higher adult adiposity levels [5]. Another study of Indian
girls, who moved to Sweden, found that those with the
most stunted growth had earlier menarche as well [37].
Maternal investment is defined as a combination of two
elements: maternal resources at conception (proxied by
her size and nutritional status) and the resources provided by her to offspring though pregnancy and then
lactation, stemming from her nutritional intake [31]. For
the purpose of this study, birth weight SDS, computed
from birth weight and gestational age, is used as a
marker to reflect degree of maternal investment; this being consistent with earlier studies [5].
Low birth weight, which is an indicator of poor fetal
growth and low maternal investment, has been found to
result in lower fat free mass (FFM) in adulthood [38–
40]. This could partly explain why lower birth weight is
linked to an increased risk of CVD, since a lower muscle
mass could lead to impaired glucose regulation [38].
This is due to the fact that muscles play a critical role in
the homeostasis of blood sugar, as 70–90% of the glucose is taken up by the muscles [41] making the muscles
‘the primary tissue contributing to whole-body insulin-
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mediated glucose disposal’ [42]. Therefore, lower FFM
could lead to development of insulin resistance, which is
an impairment that contributes heavily to CVD development in adulthood [38]. Different theories have been proposed in an attempt to explain the link between prenatal
life factors and occurrence of CVD. However, further
studies still need to be carried out in order to establish
whether early malnutrition in-utero negatively influences
metabolic competence and organ physiology [31].
Aim of study

To the best of our knowledge, this study is the first one
of its kind in the UAE. It investigates how maternal investment shapes the life history pace of the offspring.
This will offer us a chance to study the extent that maternal investment influences life history pace and generates the trade-off between maturation/adiposity versus
growth/homeostatic maintenance. It then looks at
whether this trade-off increases risk of CVD in
adulthood.
Hypotheses

In healthy women from the UAE, based on the interpretations of the life history theoretical framework, we hypothesized that:
a) Those who were on the receiving end of poor
maternal investment (characterized by lower birth
weight standard deviation score (SDS)) during the
fetal period would develop earlier maturation
(proxied by earlier age of menarche).
b) Lower maternal investment, coupled with an earlier
maturational timing (proxied by earlier age of
menarche), would then lead to reduced growth
(proxied by shorter height, and leg length).
c) Lower maternal investment, coupled with an earlier
maturational timing (proxied by lower birth weight
SDS and earlier age at menarche), would then lead
to elevated CVD risk (proxied by greater waist
circumference, higher fat mass index (FMI) and
lower fat free mass index (FFMI).
d) Reduction in metabolic capacity (proxied by low
birth weight) in addition to a high metabolic load
(proxied by elevated adult adiposity and lower
FFMI) would lead to higher risk of CVD (proxied
by elevated BP).

Methods
Subjects

This was a cross-sectional study that involved 94 females
aged between 17 and 27 years with a gestational age exceeding 37 weeks. The study used convenience sampling
method for selecting healthy, Emirati females enrolled in
various governmental (public) universities in the UAE.
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The consent of participants was obtained, and data collection was carried out in the body composition laboratory at Zayed University, Dubai-UAE. The study was
reviewed and received full ethical clearance by the Zayed
University Research Ethics Committee (ZU16_016_F).
Exclusion criteria included current smokers, twins, pregnant or lactating females, those with metal parts in their
body (as this contraindicates the use of the dual energy
X-ray absorptiometry (DXA), those who reported a
weight gain or loss of more than 3 kg in the 3 months
leading up to the screening, and those with medical conditions known to impact body composition or metabolism such as diabetics, renal patients, hypertensives and
females with hormonal imbalances.
Demographics, maternal investment & maturational
timing

A structured questionnaire was used to obtain personal
data such as date of birth, sex, ethnicity, marital status,
birth order, gestational age, weight at birth, menarcheal
age, medical history, list of medications taken if any, and
family history of disease (Additional file 1). To obtain
the maternal data such as birth weight, gestational age,
and infant feeding mode/duration, participants were
asked to contact their mothers during the session.
Breastfeeding has been proven to be protective against
overweight and obesity [43]. Controlling for breast feeding reduces the confounding factors that may contribute
to weight changes, hence affecting body composition
and BP. All this information was obtained via recall, as
verifying by other records was not possible. Birth weight
SDS were computed by adjusting for gestational age.
Birth weight SDS was used to assess maternal nutritional
investment. Age at menarche was used as a marker for
timing of reproductive maturation, whereas FFMI, height
and leg length were seen as markers for growth outcomes, and FMI as the potential to invest in
reproduction, as fat mass reflects the energy reserves for
reproduction [5]. To assess potential risk of CVD, blood
pressure and waist circumference were used [5].
Anthropometry and body composition

Weight was obtained to the nearest 0.01 kg. A stadiometer was used to measure both the standing and the
sitting height (reported to the nearest 0.1 cm). The difference between sitting and standing height was then
calculated to represent leg length [44]. Both sitting
height and leg length were measured in order to gain a
full analysis of growth as stature results from changes in
length of upper and lower body segments with age. Legs
grow relatively faster than other body segments; hence,
Leg length is considered a good indicator of the ‘quality
of the environment for growth during infancy, childhood
and the juvenile years of development’ [45]. In this
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paper, similar to other studies, leg length was used to
correlate between fetal growth, sexual maturation and
lower limb growth [5, 46].
Waist circumference was measured at the narrowest
position using a nonelastic flexible tape, taken to the
nearest 0.1 cm over light clothing [47]. BMI was calculated as weight (kg)/height (m)2. WHO classifies
overweight as BMI values between 25 and 29.9 kg/m2,
and obesity ≤30 kg/m2 [48]. The use of BMI as a risk
assessment tool may not always be accurate [49];
therefore, it has been suggested that body composition may be more accurately evaluated by assessing
both fat mass and FFM [50]. These values were acquired by DXA. However, it has been pointed out
that fat mass and FFM are not adjusted for body size
and that height needs to be considered in order to
better predict risk of CVD, therefore a FMI and a fat
free mass index FFMI have been proposed [51]. FMI
is calculated as fat mass (kg)/height (m)2 and FFMI =
fat free mass (kg)/height (m)2.
Blood pressure

BP was measured using an automatic monitor (Omron,
2016) whilst the subject was seated. The reading was
taken three times (a few minutes apart) and the average
of the 3 measurements was used in analysis. The American Heart Association (AHA) classifies hypertension as
> 140 mmHg systolic and > 90 mmHg diastolic [52].
Statistics

Data was analyzed using Statistical Package for the
Social Sciences (SPSS) software Version 27. Birth
weight was adjusted for gestational age, where birth
weight SDS were calculated using the LMS method
[53]. Linear regression analysis was conducted to investigate: whether maturational timing (proxied by
age at menarche) was predicted by degree of maternal
investment (gestational age and birth weight SDS);
whether growth (height and leg length) and adult adiposity (FMI, waist circumference) were predicted by
degree of maternal investment (birth weight SDS) as
well as maturational timing (proxied by age at menarche). Linear regression analysis was also used to investigate whether CVD risk (BP, waist circumference,
FFMI and FMI) was predicted by degree of maternal
investment (birth weight SDS). Adult adiposity levels
were also used to predict BP in addition to maternal
investment predictors. Linearity and homoscedasticity
assumptions for all independent variables were met
except for waist circumference, and FMI. These were
natural log-transformed, and the regression was then
re-fitted accordingly. Statistical tests with p–values <
0.05 were considered statistically significant.
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Results
Description of study subject characteristics

A total of 94 participants were recruited in this study.
Due to 6 missing measurements, the analysis for sitting
height and leg length was done on 88. The mean age of
the participants was 19.9 years, while the mean birth
weight was found to be 3.1 kg. All those analyzed were
born to term according to conventional criteria (> 37
weeks gestation). Regarding BMI, 19 participants (20.2%)
were found to be overweight and 8 (8.5%) were obese,
and 12.8% had a waist circumference measurement
equal to or above 80 cm, which classifies them as having
an increased risk of metabolic complications (Disease
risk for type 2 diabetes, hypertension, and CVD) according to WHO classifications [47]. The mean SBP for participants was 109.1 mmHg, and the DBP was 71.6
mmHg, both mean results falling within the ‘normal’
blood pressure boundaries in accordance with classifications of the AHA [52]. Most of the participants (73.4%)
had a normal BP, 11.7% had an elevated BP, 12.8% has
stage 1 hypertension, while 2.1% had stage 2 hypertension. Descriptive statistics for all participants included in
analysis are displayed in Table 1. In addition, the majority (88%) had been breastfed with a median duration of
12 months.
Associations of maternal investment (proxied by birth
weight SDS) with maturational timing (proxied by age at
menarche)

Table 2 illustrates the regression model exploring the relationship between maternal investment (birth weight SDS)
and maturational timing (age at menarche). A negative association was found between birth weight SDS and age at
menarche; however, this was not statistically significant
(β= − 0.184 years, 95% CI (− 0.51, 0.14), p = 0.261).
Associations of maternal investment and menarcheal age
with growth (proxied by height and leg length)

When investigating the associations of birth weight SDS
and age at menarche with growth indices (height and leg
length), it was found that birth weight SDS was positively and significantly associated with both height (β =
1.342 cm, 95% CI (0.12, 2.57), p = 0.032) and leg length
(β = 0.968 cm, 95% CI (0.08, 1.86), p = 0.034). Age at menarche, on the other hand, did not show the same relationship with both growth indices (Table 3). When we
looked at the effect size, we noticed that highest birth
weight SDS is predicted to be associated with 5.77 cm
increase in height compared to the lowest birth weight
SDS. This is not an insignificant amount, though it is
within the sample’s standard deviation in height which is
6 cm. From Another side, the highest birth weight SDS
is predicted to be associated with 4.16 cm increase in leg
length compared to the lowest birth weight SDS. This is
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Table 1 Description of study subject characteristics
N

Minimum

Maximum

Mean ± SD

94

2

4

3.1 ± 0.5

Development
Birth weight (kg)
Gestational age (weeks)

94

37

42

39.5 ± 1.04

Birth Weight SDS

94

−2.57

1.73

−0.033 ± 1.001

Age at menarche (years)

94

9

16

12.5 ± 1.6

Age (years)

94

17

27

19.7 ± 1.9

Weight (kg)

94

36.1

102.9

57.7 ± 12.6

Height (cm)

94

144.1

176

158.8 ± 6.0

Sitting height (cm)

88

74.8

92.1

83.1 ± 3.1

Leg length (cm)

88

66

84.9

76.0 ± 4.1

Waist circumference (cm)

94

54

102.2

68.8 ± 9.4

Adulthood

Fat (%)

94

23.9

52.9

39.2 ± 6.5

Fat mass (kg)

94

8.9

68.6

22.3 ± 10.0

FFM (kg)

94

23.7

47.1

33.8 ± 5.0

FFMI (kg/m2)

94

9.7

17.8

13.4 ± 1.6

FMI (kg/m2)

94

3.8

26

9.2 ± 4.0

BMI (kg/m2)

94

15.8

38.9

22.8 ± 4.4

SBP (mmHg)

94

73.7

139

109.1 ± 10.5

DBP (mmHg)

94

49.7

97

71.6 ± 7.9

circumference compared to the lowest birth weight SDS.
This is not an insignificant amount, though it is within the
sample’s standard deviation in waist circumference which is
9.4 cm. When age was accounted for in the models, it
showed significant result only with FFMI (β = 0.217 years,
95% CI (0.05, 0.38), p = 0.011). In this same model, age at
menarche showed significant association with FFMI as well
(β = − 0.222 years, 95% CI (− 0.42, − 0.02), p = 0.029), where
β-coefficient of age at menarche dropped from − 0.181
(95% CI -0.38, 0.02) to − 0.222 (95% CI -0.42, − 0.02) with a
change in p-value to < 0.05. When duration of breast feeding (months) was introduced to the models, positive but
not significant associations were found (p > 0.05) with waist
circumference, FMI and FFMI.

not an insignificant amount, though it is slightly higher
than the sample’s standard deviation in leg length which
is 4.1 cm.
Associations of maternal investment and maturational
timing (proxied by age at menarche) with CVD risk
(proxied by waist circumference, FMI and FFMI)

Table 4 displays the associations of birth weight SDS and
age at menarche with adult adipose indices (FMI and waist
circumference). Menarcheal age was significantly and inversely associated with FMI (β = − 0.080 cm, 95% CI (−
0.13, − 0.03), p = 0.002), indicating higher adult adiposity
with earlier puberty. Menarcheal age was not significantly
associated with waist circumference and FFMI (p > 0.05).
On the other hand, birth weight SDS was positively and significantly associated with waist circumference (β = 0.035
cm, 95% CI (0.01, 0.06), p = 0.009), FMI (β = 0.087 cm, 95%
CI (0.01, 0.16), p = 0.027), and FFMI (β = 0.485 cm, 95% CI
(0.17, 0.80), p = 0.003). The highest birth weight SDS is predicted to be associated with 1.16 cm increase in waist

Associations of maternal investment (low birth weight)
and adult tissue masses (metabolic load) with CVD risk
(proxied by systolic and diastolic blood pressure)

Table 5 assesses the associations of birth weight SDS
(maternal investment) and adult body composition

Table 2 Maternal investment predictor of age at menarche
Outcome

Predictors

β

SE

p-value

R2

Age at Menarche (year)

Constant

12.462

0.162

< 0.001

0.014

Birth Weight SDS

-0.184

0.163

0.261

β change in the outcome resulting from a one-unit change in the predictor value, SE Standard Error, p significance < 0.05, R2 % of variance explained by
the model
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Table 3 Developmental predictors of adult stature
Outcome
Height (cm)

Leg Length (cm)

Predictors

β

SE

p-value

R2
0.061

Constant

152.370

4.940

< 0.001

Birth Weight SDS

1.342

0.617

0.032

Age at menarche (year)

0.522

0.393

0.188

Constant

73.258

3.412

< 0.001

Birth Weight SDS

0.968

0.449

0.034

Age at menarche (year)

0.222

0.270

0.415

0.030

β change in the outcome resulting from a one-unit change in the predictor value, SE Standard Error, p significance < 0.05, R2 % of variance explained by
the model.

(FMI, FFMI, and waist circumference) with blood pressure regulation (marker of CVD risk). Birth weight SDS
was not found to be significantly associated with either
SBP or DBP in any of the models described below (p >
0.05). However, all indices of adult adiposity (FMI and
waist circumference) and FFMI were positively and significantly associated with SBP. Regarding DBP, the relationship was only negatively and significantly associated
with FFMI (β = − 1.6111 kg/m2, 95% CI (− 2.63, − 0.60),
p = 0.002). When age was introduced to the BP regression models, no significant changes in the associations
were found.

Discussion
This study was set out to test the hypothesis that maternal investment in utero would shape the life history pace
of the offspring. An accelerated life history pace

(assessed by earlier menarcheal age) would cause the individual to prioritize reproduction overgrowth and
homeostatic maintenance. In other words, the individual
develops higher energy stores for reproductive purposes,
and present with reduced growth and increased risk for
chronic disease through poorer BP regulation, lower
FFMI and higher central adiposity. In a sample of 94
young Emirati women (17–27 years), our results showed
that birth weight SDS was positively and significantly associated with both height and leg length, while age at
menarche did not show the same relationship. Body fat
was inversely associated with menarcheal age, but not
waist circumference (p > 0.05). Birth weight SDS was
positively and significantly associated with waist circumference, FMI, and FFMI. All indices of adult adiposity
(FMI and waist circumference) and FFMI were positively
and significantly associated with SBP. Regarding DBP,

Table 4 Developmental predictors of maternal investment, age at menarche, adult adiposity and FFMI indices
Outcome

Predictors

β

SE

p-value

R2

Ln Waist Circumference (cm)

Constant

4.368

0.105

< 0.001

0.100

Birth Weight SDS

0.035

0.013

0.009

Age at menarche (year)

−0.012

0.008

0.171

Constant

3.145

0.309

< 0.0001

Ln FMI (kg/m2)

FFMI (kg/m2)

Ln Waist Circumference (cm)

FFMI (kg/m2)

Birth Weight SDS

0.087

0.039

0.027

Age at menarche (year)

−0.080

0.025

0.002

Constant

15.650

1.281

< 0.001

Birth Weight SDS

0.485

0.160

0.003

Age at menarche (year)

−0.181

0.102

0.079

Constant

4.566

0.161

< 0.001

Birth Weight SDS

0.038

0.013

0.005

Age at menarche (year)

−0.009

0.008

0.264

Breast feeding (months)

−0.011

0.007

0.110

Constant

11.879

1.915

< 0.001

Birth Weight SDS

0.431

0.157

0.007

Age at menarche (year)

−0.222

0.100

0.029

Age (year)

0.217

0.084

0.011

β change in the outcome resulting from a one-unit change in the predictor value, SE Standard Error, p significance < 0.05, R2 % of variance explained by
the model

0.162

0.132

0.192

0.192
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Table 5 Capacity-load models of systolic and diastolic blood pressure (SBP and DBP)
Outcome

Predictors

β

SE

p-value

R2

Constant

89.437

5.733

< 0.001

0.152

SBP (mmHg)
Model 1

Model 2

Model 3

Birth Weight SDS

1.124

1.052

0.288

Ln FMI (kg/m2)

9.177

2.630

0.001

Constant

−36.36

32.85

0.271

Birth Weight SDS

1.370

1.020

0.183

Ln Waist Circumference (cm)

34.440

7.780

< 0.001

Constant

85.313

9.126

0 < 0.001

Birth Weight SDS

1.134

1.102

0.306

FFMI (kg/m2)

1.778

0.677

0.010

Constant

78.981

4.606

< 0.001

Birth Weight SDS

−0.146

0.845

0.863

Ln FMI (kg/m2)

−3.431

2.113

0.108

0.240

0.106

DBP (mmHg)
Model 1

Model 2

Model 3

Constant

104.76

28.09

< 0.001

Birth Weight SDS

−0.060

0.880

0.950

Ln Waist Circumference (cm)

−7.850

6.650

0.240

Constant

93.199

6.877

< 0.001

Birth Weight SDS

0.341

0.830

0.682

FFMI (kg/m2)

−1.611

0.510

0.002

0.032

0.020

0.102

β change in the outcome resulting from a one-unit change in the predictor value, SE Standard Error, p significance < 0.05, R2 % of variance explained by
the model.

the relationship was negatively and significantly associated with FFMI only.
Our data showed an inverse yet not significant association between birth weight and age at menarche,
this did not reach significance; a finding which does
not align with findings of some other studies [5, 37,
54]. An explanation given to this is that those born
with lower birth weights present with higher amounts
of adrenal concentrations in circulation, which results
in earlier attainment of menarche [55]. However,
these findings remain inconsistent across studies, as
the opposite association has been demonstrated as
well; that those born larger experience earlier menarche [56]. An alternative explanation offered for this
phenomenon is that both elevated insulin-like growth
factor-1 and leptin levels associated with a higher
birth weight could trigger earlier menarche [55, 56].
Lack of observed significance in our study could also
be attributed to failure in incorporating other factors
that could affect age at menarche such as length at
birth and postnatal growth rate. The suggested theoretical framework is not upheld in this population,
which provokes further research into the specific environments and circumstances in which the relationship between birth weight and age at menarche is
established.

A study in the Philippines concluded that menarcheal
age was not significantly associated with birth weight
alone, however ‘girls who were relatively long and thin
at birth attained menarche approximately 6 months earlier than did girls who were short and light’ [57]. Recent
research by Wells et al., in 2019, presented a theoretical
model derived from life history theory where the researchers hypothesized that with lower maternal investment, early offspring reproduction was favored, body
immune function was elevated, and risk-prone behaviors
were increased. Results showed that daughters with early
first reproduction had ‘growth trajectory favoring weight
gain at the expense of linear growth’ [58]. This indicates
that more markers need to considered, other than just
early menarche, before deriving definitive conclusions
about indicators of fast life history strategy.
Moreover, our findings support the hypothesis stating
that lower maternal investment (lower birth weight) is
linked to reduction in growth (proxied by height and leg
length). This finding is consistent with earlier studies
that reported the effect of birth weight on adult height
[5, 59]. This is an important conclusion as adult height
has been demonstrated to be inversely and significantly
linked to mortality due to coronary heart disease [59].
Lower leg length measurements, in specific, may relate
to higher risk of fatness, coronary heart disease and
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diabetes [45]. Independent of any other indicator, in our
analysis, for every 1 cm increase in leg length, waist circumference increased by 1.01 cm (p = 0.005). Leg length
was not significantly predictive of FFMI, FMI, SBP, and
DBP. Additionally, those born small for gestational age
and achieving shorter height were found to be associated
with elevated sympathetic nerve activity [60]. This is
suggested to be the link connecting maternal investment
(birth weight), adult height and risk of hypertension and
CVD [61]; not excluding the aforementioned function of
nutrition and its effect on prenatal and postnatal growth.
In our analysis, lower birth weight was not linked to
elevated adult adiposity levels, in fact the data showed
the opposite association: the higher the birth weight, the
higher the adult central adiposity (waist circumference).
On the other hand, an earlier menarche was found to be
associated with higher adult adiposity markers when adjusted for age. Our results are consistent with other findings reported in the meta-analysis conducted by Prentice
and Viner in 2013 [62]. However, it is unclear whether
earlier menarche is due to 1) fast postnatal catch-up
growth following retarded intrauterine growth in the
presence of nutritional affluence (associated with higher
adult adiposity), or 2) low birth weight induced an increase in body fat in later life, or 3) both [61]. It is well
documented that body composition changes with age,
where fat mass increases and muscle mass decreases
[63]. Hence, age was accounted for in the adiposity regression models (waist circumference and FMI). The
analysis showed that age inclusion did not affect the results. This could be explained by the fact that our age
group is young, hence no major shifts in body composition is seen at this stage of life [64]. Knowing the physical activity level could have given a better interpretation
to the findings of both fat mass and fat free mass.
Clinical and experimental studies revealed that IUGR
is associated with a significantly higher incidence of
metabolic, renal and CVD in adult life where ‘IUGR directly cause cardiovascular alterations independent of
pre-existing metabolic disease’ [65]. It has been proposed
that early growth restriction in the womb due to lower
maternal investment has been linked to higher rates of
CVD risk by altering homeostatic capacity for blood
pressure regulation [66], as well as increasing insulinemia [67]. Falkner stated that SBP is lowered by 1–2
mmHg with every kg increase in birth weight [68]. Contrary to the latter and other findings [5, 69], in this
study, birth weight was not found to be indicative of
adult blood pressure homeostasis as none of the models
showed a significant relationship. Worth noting that, in
all the SBP models, for every 1 unit increase in the BW
SDS predicted an increase of 1.1 to 1.3 mmHg in SBP.
As for the DBP, there was a general drop with increases
in birth weight.
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However, indices of adult adiposity were found to be
positively and highly significantly linked to SBP. This
stresses the importance of ‘metabolic load’ and postnatal environmental stressors on the development of disease rather than just birth weight. It is also important to
note that while some studies have supported the link between birth weight and increased blood pressure, these
findings were inconsistent. A study looking into the association between intrauterine growth and obesity suggested that it could be more useful to assess weight at
birth “relative to genetic potential, indicated by the size
of the parents or by the individuals body height” [21].
This is due to the evidence that support the theory that
failure to reach growth potential has a higher association
with blood pressure than solely birth weight [32]. Therefore, models that include post-natal growth and take
into account parental genetics would be important to
gain a better understanding of links to blood pressure
regulation.
Waist circumference was found to be positively associated with birth weight SDS. This indicates that
higher birth size equates to higher adult central adiposity. Some studies had found inverse associations
between birth weight and abdominal obesity in adulthood than not [16–18].
Size at birth was also significantly and positively associated with FFMI. To explain why those who are born
smaller end up with less adult fat free tissue mass, it has
been suggested that suboptimal nutrition in prenatal
period would restrict insulin secretions by causing
hypoglycemia and so an upsurge in protein breakdown
and a reduction in protein accretion [38]. Another pathway through which poor intrauterine conditions could
affect FFM in adulthood is by lowering circulating levels
of insulin-like growth factor 1, which in turn could affect
intrauterine muscle growth [38]. Kuh et al. [70] added
that the number of muscle fibers established at birth is
related to birth weight. So, low FFM in those born
smaller reduces metabolic capacity in adulthood and
therefore increases disease risk especially in those who
are subjected to an affluent environment [31].
It is important to note that although this type of study
may offer us a chance to explore the links between maternal influences in prenatal period and adult disease
risk, the issue remains much more multifaceted and
there exist numerous limitations that make interpretation more complex. It is difficult to determine whether
the heightened risk was due to lack of maternal investment and not attributable to other influences.
There were several limitations to the study. First, our
study was cross-sectional, hence the inability to make
causal relationship between early life events and their effect on later life outcomes [71]. Second, a relatively small
sample size using a convenient sampling strategy was
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recruited, therefore impacting the generalizability of our
results. Third, self-reporting was used to obtain participant information such as birth weight, gestational age,
age at menarche, and breastfeeding duration. Our inability to verify this information by any other means such as
hospital records meant that there is a possibility of recall
bias due to memory limitations, which potentially
threatens the internal validity of the study [72]. Also, recall might bias the mean measurements, reducing the
variance and therefore probably masking relationships
between variables. Fourth, there are many confounding
factors that we did not account for and could have affected the study outcomes in terms of weight and body
composition changes later in life or prenatal development, including postnatal circumstances such as dietary
intake, physical activity levels and stress [5, 21]; maternal
smoking habits [21, 73], and maternal blood pressure
[13]. Finally, although socioeconomic data [74] was not
collected, the UAE is a high-income country [75], and
public universities are tuition-free for UAE nationals.
Hence, it is safe to generalize that the sample population’s socioeconomic status would be representative of
that of the national population. Overall, we consider this
study relatively preliminary and encourage replication.

Conclusion
This is a pioneer study in the UAE that sheds the light
on the link between the intrauterine environment and
potential disease risk. Although the study did not provide evidence for the proposed link between degree of
maternal investment and menarcheal age, predictors of
low maternal investment resulted in shorter height in
adulthood. Earlier maturation was linked to higher adult
adiposity but was not indicative of fat distribution. As
for CVD risk, elevated blood pressure and adult central
adiposity were linked to higher birth weight and/or gestational age, negating the hypothesis that weak maternal
investment would result in hypertension. On the other
hand, those born small were found to have lower FFM,
which is indicative of higher CVD risk through possible
interaction with glucose uptake mechanisms. Higher
adult adiposity was also found indicative of higher SBP.
This reiterates the role a higher metabolic load has on
risk of disease. Over the past years, the UAE has witnessed developmental leaps and considerable changes in
different life aspects naming health, economy, industry,
education and most importantly lifestyle and eating
habits [76]. What makes this research novel is the study
population and the lifestyle changes that they are exposed to as a result of modernization and globalization.
Hence, it would be interesting to examine our study hypotheses and assess the extent of how modernization
impacts future mothers and their offspring. Moreover, in
order to halt the epidemic of rising CVD diseases, the
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pathogenesis of the disease needs to be addressed. The
idea that disease originates so early in human life can
further our understanding and influence action. Health
policies focusing on improving maternal nutrition during
pregnancy are needed in order to prevent intrauterine
malnutrition. This would help relieve not only the burden of morbidity and associated mortality but also lessen
the massive economic burden that arises with chronic
diseases.
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